Showing 1 - 18 results of 18 for search 'Shiow Lin Pan', query time: 0.05s Refine Results
  1. 1
    MPT0G413, A Novel HDAC6-Selective Inhibitor, and Bortezomib Synergistically Exert Anti-tumor Activity in Multiple Myeloma Cells

    MPT0G413, A Novel HDAC6-Selective Inhibitor, and Bortezomib Synergistically Exert Anti-tumor Activity in Multiple Myeloma Cells by Fang-I Huang, Yi-Wen Wu, Ting-Yi Sung, Jing-Ping Liou, Mei-Hsiang Lin, Shiow-Lin Pan, Shiow-Lin Pan, Shiow-Lin Pan, Chia-Ron Yang

    Published 2019-04-01
    Get full text
    Article
  2. 2
    A Novel Selective JAK2 Inhibitor Identified Using Pharmacological Interactions

    A Novel Selective JAK2 Inhibitor Identified Using Pharmacological Interactions by Tony Eight Lin, Wei-Chun HuangFu, Wei-Chun HuangFu, Min-Wu Chao, Tzu-Ying Sung, Chao-Di Chang, Yi-Ying Chen, Jui-Hua Hsieh, Huang-Ju Tu, Han-Li Huang, Shiow-Lin Pan, Shiow-Lin Pan, Shiow-Lin Pan, Kai-Cheng Hsu, Kai-Cheng Hsu

    Published 2018-12-01
    Get full text
    Article
  3. 3
    α-Tomatine-mediated anti-cancer activity in vitro and in vivo through cell cycle- and caspase-independent pathways.

    α-Tomatine-mediated anti-cancer activity in vitro and in vivo through cell cycle- and caspase-independent pathways. by Min-Wu Chao, Chun-Han Chen, Ya-Ling Chang, Che-Ming Teng, Shiow-Lin Pan

    Published 2012-01-01
    Get full text
    Article
  4. 4
    MT-4 suppresses resistant ovarian cancer growth through targeting tubulin and HSP27.

    MT-4 suppresses resistant ovarian cancer growth through targeting tubulin and HSP27. by Hui Chen Pai, Sunil Kumar, Chien-Chang Shen, Jing Ping Liou, Shiow Lin Pan, Che Ming Teng

    Published 2015-01-01
    Get full text
    Article
  5. 5
    Anticancer Study of a Novel Pan-HDAC Inhibitor MPT0G236 in Colorectal Cancer Cells

    Anticancer Study of a Novel Pan-HDAC Inhibitor MPT0G236 in Colorectal Cancer Cells by Feng-Lung Tsai, Han-Li Huang, Mei-Jung Lai, Jing-Ping Liou, Shiow-Lin Pan, Chia-Ron Yang

    Published 2023-08-01
    Get full text
    Article
  6. 6
    Effectiveness of anti-erythropoietin producing Hepatocellular receptor Type-A2 antibody in pancreatic cancer treatment

    Effectiveness of anti-erythropoietin producing Hepatocellular receptor Type-A2 antibody in pancreatic cancer treatment by Fu-Ling Chang, Keng-Chang Tsai, Tsai-Yu Lin, Chen-Wei Chiang, Shiow-Lin Pan, Yu-Ching Lee

    Published 2023-11-01
    Get full text
    Article
  7. 7
    Gene Expression Signature-Based Approach Identifies Antifungal Drug Ciclopirox As a Novel Inhibitor of HMGA2 in Colorectal Cancer

    Gene Expression Signature-Based Approach Identifies Antifungal Drug Ciclopirox As a Novel Inhibitor of HMGA2 in Colorectal Cancer by Yu-Min Huang, Chia-Hsiung Cheng, Shiow-Lin Pan, Pei-Ming Yang, Ding-Yen Lin, Kuen-Haur Lee

    Published 2019-11-01
    Get full text
    Article
  8. 8
    Investigating the potential effects of selective histone deacetylase 6 inhibitor ACY1215 on infarct size in rats with cardiac ischemia-reperfusion injury

    Investigating the potential effects of selective histone deacetylase 6 inhibitor ACY1215 on infarct size in rats with cardiac ischemia-reperfusion injury by Chao-Feng Lin, Kai-Cheng Hsu, Wei-Chun HuangFu, Tony Eight Lin, Han-Li Huang, Shiow-Lin Pan

    Published 2020-03-01
    Get full text
    Article
  9. 9
    Dehydrocostuslactone suppresses angiogenesis in vitro and in vivo through inhibition of Akt/GSK-3β and mTOR signaling pathways.

    Dehydrocostuslactone suppresses angiogenesis in vitro and in vivo through inhibition of Akt/GSK-3β and mTOR signaling pathways. by Chih-Ya Wang, An-Chi Tsai, Chieh-Yu Peng, Ya-Ling Chang, Kuo-Hsiung Lee, Che-Ming Teng, Shiow-Lin Pan

    Published 2012-01-01
    Get full text
    Article
  10. 10
    NPRL-Z-1, as a new topoisomerase II poison, induces cell apoptosis and ROS generation in human renal carcinoma cells.

    NPRL-Z-1, as a new topoisomerase II poison, induces cell apoptosis and ROS generation in human renal carcinoma cells. by Szu-Ying Wu, Shiow-Lin Pan, Zhi-Yan Xiao, Jui-Ling Hsu, Mei-Chuan Chen, Kuo-Hsiung Lee, Che-Ming Teng

    Published 2014-01-01
    Get full text
    Article
  11. 11
    A Novel Dual HDAC6 and Tubulin Inhibitor, MPT0B451, Displays Anti-tumor Ability in Human Cancer Cells in Vitro and in Vivo

    A Novel Dual HDAC6 and Tubulin Inhibitor, MPT0B451, Displays Anti-tumor Ability in Human Cancer Cells in Vitro and in Vivo by Yi-Wen Wu, Kai-Cheng Hsu, Hsueh-Yun Lee, Tsui-Chin Huang, Tony E. Lin, Yi-Ling Chen, Ting-Yi Sung, Jing-Ping Liou, Jing-Ping Liou, Wendy W. Hwang-Verslues, Wendy W. Hwang-Verslues, Shiow-Lin Pan, Shiow-Lin Pan, Wei-Chun HuangFu, Wei-Chun HuangFu

    Published 2018-03-01
    Get full text
    Article
  12. 12
    Physalin F induces cell apoptosis in human renal carcinoma cells by targeting NF-kappaB and generating reactive oxygen species.

    Physalin F induces cell apoptosis in human renal carcinoma cells by targeting NF-kappaB and generating reactive oxygen species. by Szu-Ying Wu, Yann-Lii Leu, Ya-Ling Chang, Tian-Shung Wu, Ping-Chung Kuo, Yu-Ren Liao, Che-Ming Teng, Shiow-Lin Pan

    Published 2012-01-01
    Get full text
    Article
  13. 13
    The study of a novel CDK8 inhibitor E966-0530–45418 that inhibits prostate cancer metastasis in vitro and in vivo

    The study of a novel CDK8 inhibitor E966-0530–45418 that inhibits prostate cancer metastasis in vitro and in vivo by Tai-Yuan Ho, Ting-Yi Sung, Shiow-Lin Pan, Wei-Jan Huang, Kai-Cheng Hsu, Jui-Yi Hsu, Tony Eight Lin, Chia-Ming Hsu, Chia-Ron Yang

    Published 2023-06-01
    Get full text
    Article
  14. 14
    Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status

    Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status by Min-Wu Chao, Li-Hsun Chang, Huang-Ju Tu, Chao-Di Chang, Mei-Jung Lai, Yi-Ying Chen, Jing-Ping Liou, Che-Ming Teng, Shiow-Lin Pan

    Published 2019-05-01
    Get full text
    Article
  15. 15
    The anticancer effects of MPT0G211, a novel HDAC6 inhibitor, combined with chemotherapeutic agents in human acute leukemia cells

    The anticancer effects of MPT0G211, a novel HDAC6 inhibitor, combined with chemotherapeutic agents in human acute leukemia cells by Huang-Ju Tu, Yi-Jyun Lin, Min-Wu Chao, Ting-Yi Sung, Yi-Wen Wu, Yi-Ying Chen, Mei-Hsiang Lin, Jing-Ping Liou, Shiow-Lin Pan, Chia-Ron Yang

    Published 2018-12-01
    Get full text
    Article
  16. 16
    A novel dual HDAC and HSP90 inhibitor, MPT0G449, downregulates oncogenic pathways in human acute leukemia in vitro and in vivo

    A novel dual HDAC and HSP90 inhibitor, MPT0G449, downregulates oncogenic pathways in human acute leukemia in vitro and in vivo by Yi-Wen Wu, Min-Wu Chao, Huang-Ju Tu, Liang-Chieh Chen, Kai-Cheng Hsu, Jing-Ping Liou, Chia-Ron Yang, Shih-Chung Yen, Wei-Chun HuangFu, Shiow-Lin Pan

    Published 2021-05-01
    Get full text
    Article
  17. 17
    In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer

    In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer by Chao-Di Chang, Min-Wu Chao, Hsueh-Yun Lee, Yi-Ting Liu, Huang-Ju Tu, Ssu-Ting Lien, Tony Eight Lin, Tzu-Ying Sung, Shih-Chung Yen, Sing-Han Huang, Kai-Cheng Hsu, Shiow-Lin Pan

    Published 2023-12-01
    Get full text
    Article
  18. 18
    Identification of a dual TAOK1 and MAP4K5 inhibitor using a structure-based virtual screening approach

    Identification of a dual TAOK1 and MAP4K5 inhibitor using a structure-based virtual screening approach by Min-Wu Chao, Tony Eight Lin, Wei-Chun HuangFu, Chao-Di Chang, Huang-Ju Tu, Liang-Chieh Chen, Shih-Chung Yen, Tzu-Ying Sung, Wei-Jan Huang, Chia-Ron Yang, Shiow-Lin Pan, Kai-Cheng Hsu

    Published 2021-01-01
    Get full text
    Article

Search Tools: